Interestingly, a previous paper from the same group revealed that aggressive triple negative breast and melanoma cancers overexpress Nodal, an embryonic morphogen of the TGF-β family (47) and a a putative Notch/RBPJ signaling pathway target (48). The gene discussed is NODAL; the disease is cancer.